The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 58.00
Bid: 55.00
Ask: 58.00
Change: 1.70 (3.02%)
Spread: 3.00 (5.455%)
Open: 55.20
High: 58.00
Low: 55.20
Prev. Close: 56.30
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share purchase by a PCA

4 Mar 2019 17:31

RNS Number : 8023R
Accsys Technologies PLC
04 March 2019
 

4 March 2019 AIM: AXS

Euronext Amsterdam: AXS

 

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Share purchase by a PCA of a Non-Executive Director

 

Accsys, the fast growing and sustainable chemical technology group, was notified that, on Friday 1 March 2019 and Monday 4 March 2019, Anthony Christopher Mair who is a person closely associated ("PCA") with Accsys' Non-Executive Director Sue Farr, purchased in total 25,000 ordinary shares of €0.05 in the Company ("Shares") at a price of £1.15 per Share on 1 March 2019 and £1.155 per Share on 4 March 2019.

 

The following notifications are made under article 19 of the Market Abuse Regulation ("MAR") relating to certain transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them in the shares of the Company.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

 

Name

Anthony Christopher Mair

2.

Reason for the Notification

 

Position/Status

The notification concerns a person closely associated with a person discharging managerial responsibilities, being Sue Farr, Non-Executive Director

 

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Name

Accsys Technologies plc

 

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the Financial instrument, type of instrument

Ordinary shares of €0.05 each in Accsys Technologies plc ("Shares")

 

Identification code

GB00BQQFX454

 

Nature of the Transaction

Purchase of Shares

 

Price(s) and volume(s)

Price(s) £

Volume(s)

1.15

15,000

 

Aggregated information:

N/A single transaction

 

Date of the transaction

1 March 2019

 

Place of the transaction

London Stock Exchange (XLON); AIM Market

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Description of the Financial instrument, type of instrument

Ordinary shares of €0.05 each in Accsys Technologies plc ("Shares")

 

Identification code

GB00BQQFX454

 

Nature of the Transaction

Purchase of Shares

 

Price(s) and volume(s)

Price(s) £

Volume(s)

1.155

10,000

 

Aggregated information

N/A single transaction

 

Date of the transaction

4 March 2019

 

Place of the transaction

London Stock Exchange (XLON); AIM Market

 

 

ACCSYS TECHNOLOGIES PLC ("Accsys" of "de Vennootschap")

 

Aandelenaankoop door een PCA van een Non-Executive Director

 

Accsys, de snelgroeiende en duurzame chemische technologie groep, is geinformeerd dat Anthony Christopher Mair, een persoon nauw verbonden ("PCA") met Accsys Non-Executive Director Sue Farr, op vrijdag 1 maart 2019 en maandag 4 maart 2019 in totaal 25.000 gewone aandelen in de Vennootschap ("Aandelen") van € 0,05 per aandelen heeft gekocht tegen een prijs van £1,15 per aandeel op 1 maart 2019 en £1,155 per aandeel op 4 maart 2019.

 

De onderstaande kennisgevingen worden gedaan op grond van artikel 19 van de Market Abuse Regulation ("MAR") met betrekking tot bepaalde transacties door personen met leidinggevende verantwoordelijkheden ("PDMR") en personen die nauw met hen verbonden zijn, in aandelen van de Vennootschap.

 

1.

Gegevens over de persoon met leidinggevende verantwoordelijkheden / nauw verbonden persoon

 

Naam

Anthony Christopher Mair

2.

Reden voor de kennisgeving

 

Positie/Status

De kennisgeving betreft een persoon die nauw betrokken is bij een persoon met leidinggevende verantwoordelijkheden, zijnde Sue Farr, Non-Executive Director

 

Eerste kennisgeving / wijziging

Eerste kennisgeving

3.

Gegevens van de emittent, deelnemer aan de emissierechtenmarkt, veilingplatform, veilingmeester of veilingmonitor

 

Naam

Accsys Technologies plc

 

LEI

213800HKRFK8PNUNV581

4.

Details van de transactie (s): sectie die moet worden herhaald voor (i) elk type instrument; (ii) elk type transactie; (iii) elke datum; en (iv) elke plaats waar transacties zijn uitgevoerd

 

Beschrijving van het financiële instrument, type instrument

Gewone aandelen van elk € 0,05 in Accsys Technologies plc ("aandelen")

 

Identificatiecode

GB00BQQFX454

 

Aard van de transactie

Aankoop van aandelen

 

Prijs en volume

Prijs £

Volume

1,15

15.000

 

Geaggregeerde informatie

Niet toepasbaar

 

Datum van de transactie

1 maart 2019

 

Plaats van de transactie

London Stock Exchange (XLON); AIM Market

4.

Details van de transactie (s): sectie die moet worden herhaald voor (i) elk type instrument; (ii) elk type transactie; (iii) elke datum; en (iv) elke plaats waar transacties zijn uitgevoerd

 

Beschrijving van het financiële instrument, type instrument

Gewone aandelen van elk € 0,05 in Accsys Technologies plc ("aandelen")

 

Identificatiecode

GB00BQQFX454

 

Aard van de transactie

Aankoop van aandelen

 

Prijs en volume

Prijs £

Volume

1,155

10.000

 

Geaggregeerde informatie

Niet toepasbaar

 

Datum van de transactie

4 maart 2019

 

Plaats van de transactie

London Stock Exchange (XLON); AIM Market

 

- Ends -

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

 

via MHP Communications

Numis Securities

Nominated Adviser: Jamie Lillywhite

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

 

Off the Grid

(The Netherlands)

Frank Neervoort

Yvonne Derske

+31 681 734 236

+31 222 379 666

 

Notes to editors:

 

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKQDBOBKDANK
Date   Source Headline
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.